Effectiveness of varied dose of pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C

被引：0
|
作者：
Midha, V. [1 ]
Sood, A. [1 ]
Hissar, S. S. [2 ]
Sood, N. [1 ]
Kumar, M. [2 ]
Sarin, S. K. [2 ]
机构：
[1] DMC, Dept Gastroenterol, Ludhiana, Punjab, India
[2] GB Pant Hosp, Dept Gastroenterol, New Delhi, India
来源：
PROCEEDINGS OF THE 16TH CONFERENCE OF THE ASIAN PACIFIC ASSOCIATION FOR THE STUDY OF THE LIVER | 2006年
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
下载
收藏
页码：1 / +
页数：2
相关论文
共 50 条
  • [41] Combination of interferon induction therapy and ribavirin in chronic hepatitis C
    Ferenci, P
    Brunner, H
    Nachbaur, K
    Datz, C
    Gschwantler, M
    Hofer, H
    Stauber, R
    Hackl, F
    Jessner, W
    Rosenbeiger, M
    Munda-Steindl, P
    Hegenbarth, K
    Gangl, A
    Vogel, W
    HEPATOLOGY, 2001, 34 (05) : 1006 - 1011
  • [42] Retinal vein thrombosis associated with pegylated-interferon and ribavirin combination therapy for chronic hepatitis C
    Iman Zandieh
    Mohamed Adenwalla
    Cindy Cheong-Lee
    Patrick E Ma
    Eric M Yoshida
    World Journal of Gastroenterology, 2006, (30) : 4908 - 4910
  • [43] Dyspnoea in patients with chronic hepatitis C treated with pegylated interferon and ribavirin
    Garib, Junia Rios
    Garcia, Guilherme Freire
    Teixeira, Rosangela
    Lima e Silva, Francisco das Chagas
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2011, 43 (08) : 625 - 631
  • [44] Retinal vein thrombosis associated with pegylated-interferon and ribavirin combination therapy for chronic hepatitis C
    Zandieh, Iman
    Adenwalla, Mohamed
    Cheong-Lee, Cindy
    Ma, Patrick E.
    Yoshida, Eric M.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (30) : 4908 - 4910
  • [45] EFFECT OF FLUVASTATIN-COMBINED PEGYLATED-INTERFERON/RIBAVIRIN COMBINATION THERAPY ON CHRONIC HEPATITIS C
    Kondo, Chisa
    Atsukawa, Masanori
    Itokawa, Norio
    Hashimoto, Satomi
    Fukuda, Takeshi
    Matsushita, Yoko
    Kidokoro, Hideko
    Katakura, Tamaki
    Narahara, Yoshiyuki
    Nakatsuka, Katsuhisa
    Kanazawa, Hidenori
    Tsubota, Akihito
    Sakamoto, Choitsu
    HEPATOLOGY, 2011, 54 : 989A - 989A
  • [46] Using pegylated interferon and ribavirin to treat patients with chronic hepatitis C
    Ward, RP
    Kugelmas, M
    AMERICAN FAMILY PHYSICIAN, 2005, 72 (04) : 655 - 662
  • [47] Pegylated interferon plus ribavirin in chronic hepatitis c
    Bruce R. Bacon
    Current Gastroenterology Reports, 2001, 3 (1) : 84 - 84
  • [48] Pegylated Interferon and Ribavirin for the Treatment of Chronic Hepatitis C
    Kemp, William
    Roberts, Stuart
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2011, 3 : 137 - 150
  • [49] Retreatment of Egyptian Chronic Hepatitis C Patients Not Responding to Pegylated Interferon and Ribavirin Dual Therapy
    Aboushady, Mohamed
    Alwassief, Ahmed
    Abdelrazik, Mohamed
    Ziada, Dina
    Shahba, Hossam
    Elmestikawy, Amr
    Elbahrawy, Ashraf
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2019, 39 (09): : 539 - 546
  • [50] Interferon lambda 4 polymorphism affects on outcome of telaprevir, pegylated interferon and ribavirin combination therapy for chronic hepatitis C
    Nagaoki, Yuko
    Imamura, Michio
    Kawakami, Yoshiiku
    Kan, Hiromi
    Fujino, Hatsue
    Fukuhara, Takayuki
    Kobayashi, Tomoki
    Ono, Atsushi
    Nakahara, Takashi
    Naeshiro, Noriaki
    Urabe, Ayako
    Yokoyama, Satoe
    Miyaki, Daisuke
    Murakami, Eisuke
    Kawaoka, Tomokazu
    Tsuge, Masataka
    Hiramatsu, Akira
    Aikata, Hiroshi
    Takahashi, Shoichi
    Hayes, C. Nelson
    Ochi, Hidenori
    Chayama, Kazuaki
    HEPATOLOGY RESEARCH, 2014, 44 (14) : E447 - E454
12345